[1]
M. Millan Fachi, A. de Fátima Bonetti, L. Andrade Oliveira, H. Alves Oliveira Junior, e R. Camila Lucchetta, “Cost-utility analysis of rhTSH for differentiated thyroid carcinoma from a societal perspective”, JAFF, vol. 10, nº 4, nov. 2025.